Osteopontin: A potential biomarker for successful bee venom immunotherapy and a potential molecule for inhibiting IgE-mediated allergic responses

Satoshi Konno, Nobuyuki Hizawa, Masaharu Nishimura, Shau Ku Huang

研究成果: 雜誌貢獻回顧型文獻同行評審

10 引文 斯高帕斯(Scopus)

摘要

Venom immunotherapy (VIT) is proven to be curative for insect allergy, but the mechanisms and the biomarkers associated with clinical efficacy remain elusive. We report herein the discovery of a leading candidate biomarker, osteopontin (OPN), for VIT. From cDNA microarray and clustering analyses, an increased expression of OPN was found in patients who completed 5-6 years of VIT and discontinued therapy for 3-6 years as compared with the untreated group. A significantly higher level of serum OPN was found in the completed treatment group as compared with the untreated group. Following VIT, kinetically increased levels of OPN associated with reduced venom specific IgE levels were noted in subjects with large local allergic reactions to venom. These findings together with the fact that OPN is involved in Th1-associated immune response strongly suggest a role of OPN as a functional biomarker for VIT.

原文英語
頁(從 - 到)355-359
頁數5
期刊Allergology International
55
發行號4
DOIs
出版狀態已發佈 - 一月 1 2006
對外發佈

ASJC Scopus subject areas

  • 免疫學和過敏

指紋

深入研究「Osteopontin: A potential biomarker for successful bee venom immunotherapy and a potential molecule for inhibiting IgE-mediated allergic responses」主題。共同形成了獨特的指紋。

引用此